NEW INVESTOR SLIDE PRESENTATION AVAILABLE AT
WWW.MEDICURE.COM/INVESTORS
WINNIPEG, MB, Dec. 2, 2020
/CNW/ - Medicure Inc. ("Medicure" or the "Company")
(TSXV: MPH) (OTC:MCUJF), a cardiovascular pharmaceutical company,
today announces that it has retained the services of Renmark
Financial Communications Inc. ("Renmark") to conduct
investor relations activities. Additionally, the Company's
website, www.medicure.com/investors, has been updated with a
revised investor slide presentation.
"We are pleased to engage Renmark for investor relations
activities. In relation to these activities, we have updated the
investor presentation available on our website. We look forward to
working with Renmark to enhance communication with a wider
shareholder base and share the exciting developments at Medicure,"
stated Dr. Albert Friesen PhD, Chief Executive Officer of the
Company and Chair of its Board of Directors.
In consideration of the services to be provided, the fees
incurred by Medicure will be cash consideration of $5,000 per month, starting December 1, 2020 and ending on April 30, 2021.
Renmark does not have any interest, directly or indirectly, in
Medicure or its securities, or any right or intent to acquire such
an interest.
About Medicure Inc.
Medicure is a pharmaceutical
company focused on the development and commercialization of
therapies for the U.S. cardiovascular market. The present focus of
the Company is the marketing and distribution of
AGGRASTAT® (tirofiban hydrochloride) injection and
ZYPITAMAGTM (pitavastatin) tablets in the United States, where they are sold through
the Company's U.S. subsidiary, Medicure Pharma Inc. For more
information on Medicure please visit www.medicure.com. For
additional information about ZYPITAMAGTM, refer to the
full Prescribing Information.
Neither TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
View original
content:http://www.prnewswire.com/news-releases/medicure-retains-investor-relations-firm-renmark-financial-communications-inc-301183624.html
SOURCE Medicure Inc.